The National Agency For Food And Drug Administration And Control (NAFDAC) has approved the use of a herbal drug, GLUCOZIL, produced by Ambrose Alli University, Ekpoma for the treatment of diabetes mellitus.
NAFDAC’s approval of the drug for public use was made known in a press statement released and signed by the University Head, Corporate Communication, Office of the Vice-Chancellor, Mike Aladenika, on Thursday, August 24, 2023.
Dr Jonathan Emeka Emordi, the Head, Department of Pharmacology, and Sub-Dean, Basic Clinical Sciences, College of Medicine, AAU, who produced the drug, said: “GLUCOZIL is a natural product that is prepared for the treatment of diabetes mellitus.
According to him: “GLUCOZIL as a natural product, manufactured to cause a regeneration of the better cells that have been destroyed.
“If the product is used for a very long period, it will not only manage diabetes but cure it completely.”
Emordi said that GLUCOZIL can be used for the management, treatment, and cure of diabetes.
According to Emordi, GLUCOZIL has bonus clinical indications for the treatment of BPH, commonly known as enlarged prostate.
He added: “In my analysis of the product, it was discovered that it has the capacity to shrink the prostate so that surgical operations can be avoided.
“The product is scientifically tested, right dose confirmed, safety proven in both humans and animals.
”It is also capable of flushing the human system. Simply put, it is a detoxifier. It has strong anti-oxidant and anti-inflammatory activities which makes it an immune booster.”
Ambrose Alli University Vice chancellor, Prof. Sonnie Adagbonyin commended college of medicine and pharmacology department for the feat achieved.
Adagbonyin said: “We are proud of the ranking of our scholars who are determined to excel, do us proud despite the various human and environmental challenges.
“Management is proud of Dr. Emordi and I enjoin other scholars to see his achievement as motivation for them to break new grounds, open new frontiers of knowledge and innovation for the further progress of this university.”
